Medical Writing Medical Writing in Oncology Imaging techniques in oncology
mew-150pxjpg

Volume 21, Issue 1 - Medical Writing in Oncology

Imaging techniques in oncology

Abstract

Identifying and diagnosing cancerous diseases is currently one of the main tasks of today's radiologist. Every year cancer is diagnosed worldwide in over 12 million people. Within a single year, 7 million people die from cancer worldwide.

The most commonly diagnosed cancers are lung, breast, and colorectal cancers. The most common causes of cancer death are lung, stomach, and liver cancers.

Besides identifying primary tumours, it is also very important that radiology identifies possible metastases in other organs such as the liver, bones, brain, etc. at an early stage. Today all this information is gained using imaging techniques. The radiologist thus plays an important part in the treatment of people suffering from cancer.

A further important task of the radiologist using imaging techniques is judging whether oncological treatment of the tumour's course has to be initiated. In this way, the radiologist is able to make a statement as to whether the targeted oncological therapy has achieved its goal or whether in the absence of a response it has to be further adjusted.

The total medical care costs for people with cancer are approximately 20% higher than those for heart or vascular diseases, which are the second leading causes of global health costs. These high costs, however, arise as the result of many different factors such as costs of medication and the various therapy options, nursing care, and a lesser proportion also due to the application of radiological techniques.

The radiologist has many different techniques at his disposal to identify neoplasias within the body.

In principle, there are techniques using or not using X-rays.

Download the full article

References

  1. Wilking N, Jönsson B. Cancer and economics: with a special focus on cancer drugs. Oncol News 2011;6:17–9.
  2. EMA, Committee for Medicinal Products for Human Use (CHMP). Assessment report Zytiga (abiraterone). 21 July 2011. Procedure No.: EMEA/H/C/002321.
  3. EMA, Committee for Medicinal Products for Human Use (CHMP). Assessment report Yervoy (ipilimumab). 19 May 2011. Procedure No.: EMEA/H/C/002213.
  4. EMA, CHMP, Guideline on the Evaluation of Anticancer Medicinal Products in Man. London: EMA. December 2005.

Search

Articles

About the Medical Writing Journal
Oncology and medical writers
Message from the President
The war on cancer – What is the enemy, and are we winning?
Medical writing for cancer trials and submissions
Developing a treatment for ovarian cancer
The evolving landscape of medical education in oncology
Some considerations on the safety evaluation section of clinical study reports for studies with anticancer drugs
Identifying appropriate journals in which to publish original research on vaccines against human infectious diseases
New myths about English
From researcher in Europe to medical writer in India
Imaging techniques in oncology
Is cancer preventable? A literature review
A rising tide: Hospitals and social media
In the Bookstores
Journal Watch
The Webscout
Manuscript Writing
Regulatory Writing
Good Writing Practice
Out On Our Own
Translation Section

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: